Skip to main content
SpringerLink
Log in

Paclitaxel in Early Breast Cancer

A Viewpoint by Aman U. Buzdar

  • Adis Drug Profile
  • Guest Commentary
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Early Breast Cancer Trialists’ Collaborative Group. Polychemotherapy for early breast cancer: an overview of the randomized trials. Lancet 1998; 352: 930–42

    Article  Google Scholar 

  2. Levine MN, Bramwell VH, Pritchard KI. Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with nodepositive breast cancer. J Clin Oncol 1998; 16(8): 2651–8

    PubMed  CAS  Google Scholar 

  3. Misset JL, di Palma M, Delgado M. Adjuvant treatment of nodepositive breast cancer with cyclophosphamide, doxorubicin, fluorouracil, and vincristine versus cyclophosphamide, methotrexate, and fluorouracil: final report after a 16-year median follow-up duration. J Clin Oncol 1996; 14(4): 1136–45

    PubMed  CAS  Google Scholar 

  4. Hortobagyi GN, Yap HY, Blumenschein GR. Phase II evaluation of vinblastine, methotrexate and calcium leucovorin rescue in patients with refractory metastatic breast cancer. Cancer 1983; 51(5): 769–72

    Article  PubMed  CAS  Google Scholar 

  5. Assikis V, Buzdar A, Yang Y. A phase III trial of sequential adjuvant chemotherapy for operable breast carcinoma. Cancer 2003; 97(11): 2716–23

    Article  PubMed  CAS  Google Scholar 

  6. Buzdar AU, Singletary SE, Booser DJ, et al. Treatment of stage III and inflammatory breast cancer. Surg Onc Clinic N Am 1995; 4(4): 715–34

    CAS  Google Scholar 

  7. Holmes FA, Walters RS, Theriault RL. Phase II trial of Taxol, an active drug in the treatment of metastatic breast cancer. J Natl Cancer Inst 1991; 83(24): 1797–805

    Article  PubMed  CAS  Google Scholar 

  8. Reichman BS, Seidman AD, Crown JPA, et al. Paclitaxel and recombinant human granulocyte colony-stimulating factor as initial chemotherapy for metastatic breast cancer. J Clin Oncol 1993; 11(10): 1943–51

    PubMed  CAS  Google Scholar 

  9. Bishop JF, Dewar J, et al. Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancer. J Clin Oncol 1999; 17(8): 2355–64

    PubMed  CAS  Google Scholar 

  10. Nabholtz JM, Falkson G, Campos D. A phase III trial comparing doxorubicin and docetaxel to doxorubicin and cyclophosphamide as first line chemotherapy for metastatic breast cancer [abstract no. 485]. Proc Am Soc Clin Oncol 1999; 18: 127a

    Google Scholar 

  11. Green MC, Buzdar AU, Smith T, et al. Weekly paclitaxel (P) followed by FAC in the neo-adjuvant setting provides improved pathologic complete remission (PCR) rates compared to standard paclitaxel followed by FAC therapy: preliminary results of an ongoing prospective randomised trial [abstract no. 129]. Proc Soc Am Clin Oncol 2001; 20: 33

    Google Scholar 

  12. Esmaeli B, Hidaji L, Adinin RB, et al. Blockage of lacrimal drainage apparatus: a side effect of docetaxel therapy. Cancer 2003; 98(3): 504–7

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. M. D. Anderson Cancer Center, University of Texas, Houston, Texas, USA

    Aman U. Buzdar

Authors
  1. Aman U. Buzdar
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Buzdar, A.U. Paclitaxel in Early Breast Cancer. Drugs 64, 1848 (2004). https://doi.org/10.2165/00003495-200464160-00009

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-200464160-00009

Search

Navigation